About Cristina Rondinone
Form D filings for Pep2Tango Therapeutics in 2024 list Cristina Rondinone as chief executive officer and director.
Cristina Rondinone first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Cristina Rondinone in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Cristina Rondinone works with at each company, as listed on that company's latest Form D.
Pep2Tango Therapeutics, Inc. · Form D, Nov 21, 2024